AAAAAA
Results: 1-25/40
Authors:
Weetman, AP
Citation: Ap. Weetman, Determinants of autoimmune thyroid disease, NAT IMMUNOL, 2(9), 2001, pp. 769-770
Authors:
Price, A
Weetman, AP
Citation: A. Price et Ap. Weetman, Screening for central hypothyroidism is unjustified, BR MED J, 322(7289), 2001, pp. 798-798
Authors:
Kemp, EH
Waterman, EA
Weetman, AP
Citation: Eh. Kemp et al., Autoimmune aspects of vitiligo, AUTOIMMUN, 34(1), 2001, pp. 65-77
Authors:
Hunt, PJ
Marshall, SE
Weetman, AP
Bunce, M
Bell, JI
Wass, JAH
Welsh, KI
Citation: Pj. Hunt et al., Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease, CLIN ENDOCR, 55(4), 2001, pp. 491-499
Authors:
Talbot, JA
Lambert, A
Anobile, CJ
McLoughlin, JD
Price, A
Weetman, AP
Robertson, WR
Citation: Ja. Talbot et al., The nature of human chorionic gonadotrophin glycoforms in gestational thyrotoxicosis, CLIN ENDOCR, 55(1), 2001, pp. 33-39
Authors:
Zarkesh-Esfahani, H
Pockley, G
Metcalfe, RA
Bidlingmaier, M
Wu, ZD
Ajami, A
Weetman, AP
Strasburger, CJ
Ross, RJM
Citation: H. Zarkesh-esfahani et al., High-dose leptin activates human leukocytes via receptor expression on monocytes, J IMMUNOL, 167(8), 2001, pp. 4593-4599
Authors:
Hedstrand, H
Ekwall, O
Olsson, MJ
Landgren, E
Kemp, EH
Weetman, AP
Perheentupa, J
Husebye, E
Gustafsson, J
Betterle, C
Kampe, O
Rorsman, F
Citation: H. Hedstrand et al., The transcription factors SOX9 and SOX10 are vitiligo autoantigens in autoimmune polyendocrine syndrome type I, J BIOL CHEM, 276(38), 2001, pp. 35390-35395
Authors:
Kemp, EH
Waterman, EA
Ajjan, RA
Smith, KA
Watson, PF
Ludgate, ME
Weetman, AP
Citation: Eh. Kemp et al., Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroiddisease, CLIN EXP IM, 124(3), 2001, pp. 377-385
Authors:
Kemp, EH
Waterman, EA
Gawkrodger, DJ
Watson, PF
Weetman, AP
Citation: Eh. Kemp et al., Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo, CLIN EXP IM, 124(3), 2001, pp. 509-515
Authors:
Price, A
Obel, O
Cresswell, J
Catch, I
Rutter, S
Barik, S
Heller, SR
Weetman, AP
Citation: A. Price et al., Comparison of thyroid function in pregnant and non-pregnant Asian and western Caucasian women, CLIN CHIM A, 308(1-2), 2001, pp. 91-98
Authors:
Czarnocka, B
Pastuszko, D
Janota-Bzowski, M
Weetman, AP
Watson, PF
Kemp, EH
McIntosh, RS
Asghar, MS
Jarzab, B
Gubala, E
Wioch, J
Lange, D
Citation: B. Czarnocka et al., Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?, BR J CANC, 85(6), 2001, pp. 875-880
Authors:
Weetman, AP
Kemp, EH
Ridgway, JN
Watson, PF
Citation: Ap. Weetman et al., Orbital autoantigens, ENDOC UPD S, 14, 2001, pp. 1-20
Authors:
Weetman, AP
Citation: Ap. Weetman, Graves' disease by any other name?, THYROID, 10(12), 2000, pp. 1071-1072
Authors:
Price, A
Weetman, AP
Citation: A. Price et Ap. Weetman, Thyroid function tests - Thyroid stimulating hormone outside the normal range has important implications, BR MED J, 321(7268), 2000, pp. 1080-1080
Authors:
Kemp, EH
Ridgway, JN
Smith, KA
Watson, PF
Weetman, AP
Citation: Eh. Kemp et al., Autoantibodies to the flavoprotein subunit of succinate dehydrogenase: analysis of specificity in autoimmune thyroid disease, CLIN ENDOCR, 53(3), 2000, pp. 291-299
Authors:
Weetman, AP
Citation: Ap. Weetman, Controversy in thyroid disease - In response, J ROY COL P, 34(6), 2000, pp. 587-587
Authors:
Weetman, AP
Citation: Ap. Weetman, Controversy in thyroid disease - In response, J ROY COL P, 34(5), 2000, pp. 502-502
Authors:
Weetman, AP
Citation: Ap. Weetman, Controversy in thyroid disease, J ROY COL P, 34(4), 2000, pp. 374-380
Authors:
Weetman, AP
Citation: Ap. Weetman, Medical progress: Graves' disease., N ENG J MED, 343(17), 2000, pp. 1236-1248
Authors:
Zarkesh-Esfahani, SH
Kolstad, O
Metcalfe, RA
Watson, PF
Von Laue, S
Walters, S
Revhaug, A
Weetman, AP
Ross, RJM
Citation: Sh. Zarkesh-esfahani et al., High-dose growth hormone does not affect proinflammatory cytokine (tumor necrosis factor-alpha, interleukin-6, and interferon-gamma) release from activated peripheral blood mononuclear cells or after minimal to moderate surgical stress, J CLIN END, 85(9), 2000, pp. 3383-3390
Authors:
Reimand, K
Peterson, P
Hyoty, H
Uibo, R
Cooke, I
Weetman, AP
Krohn, KJE
Citation: K. Reimand et al., 3 beta-hydroxysteroid dehydrogenase autoantibodies are rare in premature ovarian failure, J CLIN END, 85(6), 2000, pp. 2324-2326
Authors:
Hunt, PJ
Marshall, SE
Weetman, AP
Bell, JI
Wass, JAH
Welsh, KI
Citation: Pj. Hunt et al., Cytokine gene polymorphisms in autoimmune thyroid disease, J CLIN END, 85(5), 2000, pp. 1984-1988
Authors:
Ajjan, RA
Kemp, EH
Waterman, EA
Watson, PF
Endo, T
Onaya, T
Weetman, AP
Citation: Ra. Ajjan et al., Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease, J CLIN END, 85(5), 2000, pp. 2020-2027
Authors:
Kilbane, MT
Ajjan, RA
Weetman, AP
Dwyer, R
McDermott, EWM
O'Higgins, NJ
Smyth, PPA
Citation: Mt. Kilbane et al., Tissue iodine content and serum-mediated I-125 uptake-blocking activity inbreast cancer, J CLIN END, 85(3), 2000, pp. 1245-1250
Authors:
Vaidya, B
Imrie, H
Geatch, DR
Perros, P
Ball, SG
Baylis, PH
Carr, D
Hurel, SJ
James, RA
Kelly, WF
Kemp, EH
Young, ET
Weetman, AP
Kendall-Taylor, P
Pearce, SHS
Citation: B. Vaidya et al., Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease, J CLIN END, 85(2), 2000, pp. 688-691